Does progesterone receptor expression during prostate cancer progression suggest a role of this receptor in stromal cell differentiation?
These results suggest that PR plays an active role in regulating stromal cell phenotypes during prostate cancer progression.
UC extent is best determined by surveillance biopsy. Among patients with long-standing UC, histologic extent fluctuates with time. Disease remission and oral mesalamine were independently associated with decreases in disease extent.